Biotech · Private company
Kythera Biopharmaceuticals
Track this companyFree. Adds Kythera Biopharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- ATX-101Phase 3 · Moderate to Severe Convexity of Submental FatClinicalTrials.gov · fetched Nov 12, 2026
- ATX-101Phase 3 · Submental FatClinicalTrials.gov · fetched Nov 12, 2026
- Deoxycholic AcidPhase 3 · Moderate to Severe Convexity of Submental FatClinicalTrials.gov · fetched Nov 12, 2026
- ATX-101 (1 mg/cm^2)Phase 2 · Submental FatClinicalTrials.gov · fetched Nov 12, 2026
- ATX-101 (2 mg/cm^2)Phase 2 · Submental FatClinicalTrials.gov · fetched Nov 12, 2026
- ATX-101 (4 mg/cm^2)Phase 2 · Submental FatClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of AgePHASE3 · COMPLETED · started Apr 1, 2014ClinicalTrials.gov NCT02123134 · fetched Nov 12, 2026
- Safety Study of ATX-101 (Deoxycholic Acid) in Subjects With Mild or Extreme Fullness of Submental FatPHASE3 · COMPLETED · started Jan 1, 2014ClinicalTrials.gov NCT02035267 · fetched Nov 12, 2026
- Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101PHASE3 · COMPLETED · started Dec 1, 2013ClinicalTrials.gov NCT02163902 · fetched Nov 12, 2026
- Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101PHASE2 · COMPLETED · started Feb 1, 2009ClinicalTrials.gov NCT02159729 · fetched Nov 12, 2026